WilliamsonP.Hypofrontality in schizophrenia: a review of the evidence.Can J Psychiatry1987; 32(5): 399–404.
2.
CampbellA., BaldessariniR.J.Prolonged pharmacologic activity of neuroleptics.Arch Gen Psychiatry1985; 42: 637.
3.
HubbardJ.W.Prolonged pharmacologic activity of neuroleptic drugs.Arch Gen Psychiatry1987; 44: 99–100.
4.
MatsumotoT.Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain.Eur J Pharmacol1983; 89: 27–33.
5.
BannonM.J., RothR.H.Pharmacology of mesocortical dopamine neurons.Pharmacol Rev1983; 35: 53–68.
6.
GurR.E.Regional brain function in schizophrenia. II: Repeated evaluation with positron emission tomography.Arch Gen Psychiatry1987; 44: 126–129.
7.
AndreasenN.Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study.Arch Gen Psychiatry1986; 43: 136–144.
8.
WeinbergerD.R., BermanK.F., ZeeR.F.Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I: Regional blood flow evidence.Arch Gen Psychiatry1986; 43: 114–124.
9.
BuchsbaumM.S.Cerebral glucography with positron tomography.Arch Gen Psychiatry1982; 39: 251–259.
BenesF.M., DavidsonJ., BirdE.D.Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.Arch Gen Psychiatry1986; 43: 31–43.
15.
MukherjeeS.Persistent tardive dyskinesia in bipolar patients.Arch Gen Psychiatry1986; 43: 342–346.
16.
JonesB.D.Factors related to tardive dyskinesia in affective disorders. Presented at 33rd Annual Meeting of the Canadian Psychiatric Association, 1983, Ottawa.
17.
DunlapC.B.Dementia praecox: some preliminary observations on brains from carefully selected cases and a consideration of certain sources of error.Am J Psychiatry1924; 80: 403–420.
